HROW - שולי רווח נקי Harrow, Inc.

Steady demand for ophthalmology products provides Harrow, Inc. (HROW) with a predictable capital inflow. Strong pricing power in surgery allows the company to dictate terms thanks to its unique combination drugs. Close partnerships with cataract and glaucoma clinics strengthen its market position. The net profit margin trend illustrates profit resilience, and -9.40 indicates the current level of this metric.
פילוחי נתונים אנליטיים מרוכזים עבור Harrow Corp (HROW)

Net margin measures the portion of profit remaining from revenue after all expenses are deducted, allowing an investor to filter out market noise through the company's sales margins and assess real operational efficiency. This metric confirms the ability of Harrow, Inc. (HROW) to convert monolithic physician loyalty and its status as an ophthalmology market leader into a sustainable financial result.